Figure 2
From: RPS23RG1 reduces Aβ oligomer-induced synaptic and cognitive deficits
PRS23RG1/Rps23rg1 mRNA levels are decreased in postmortem human AD patient and AD transgenic mouse brains.
(A) Quantification of RPS23RG1 (hRps) mRNA levels in the postmortem brains of human AD patients (left) or PD patients (right). Values were mean ± SEM (n = 8 for AD and n = 7 for PD, *p < 0.05 two-tailed Student’s t test). (B) The mRNA level of mouse Rps23rg1 (mRps) in Tg2576 AD or WT mouse brains at different ages were quantified for comparison (n = 4 at each data point, *p < 0.05, **p < 0.01, two-tailed Student’s t test).
